ASSAYS FOR DETERMINING PLASMA KALLIKREIN SYSTEM BIOMARKERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160252527A1
SERIAL NO

15030811

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITEDOSAKA-SHI OSAKA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adelman, Burt Concord, US 20 90
Conley, Gregory P Arlington, US 9 37
Faucette, Ryan Melrose, US 19 74
Kenniston, Jon A Hingham, US 13 51
Nixon, Andrew Hanover, US 38 354
Sexton, Daniel J Melrose, US 58 508
TenHoor, Christopher Hopkinton, US 23 150

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation